Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Hepatitis C virus-mediated inhibition of cathepsin S increases invariant-chain expression on hepatocyte surface.

Kim H, Mazumdar B, Bose SK, Meyer K, Di Bisceglie AM, Hoft DF, Ray R.

J Virol. 2012 Sep;86(18):9919-28. doi: 10.1128/JVI.00388-12. Epub 2012 Jul 3.

2.

Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation, and induces interleukin-10 production.

Saito K, Ait-Goughoulte M, Truscott SM, Meyer K, Blazevic A, Abate G, Ray RB, Hoft DF, Ray R.

J Virol. 2008 Apr;82(7):3320-8. doi: 10.1128/JVI.02547-07. Epub 2008 Jan 23.

3.

Human dendritic cells expressing hepatitis C virus core protein display transcriptional and functional changes consistent with maturation.

Landi A, Yu H, Babiuk LA, van Drunen Littel-van den Hurk S.

J Viral Hepat. 2011 Oct;18(10):700-13. doi: 10.1111/j.1365-2893.2010.01357.x. Epub 2010 Aug 4.

PMID:
20701679
4.

Hepatitis C virus attenuates interferon-induced major histocompatibility complex class I expression and decreases CD8+ T cell effector functions.

Kang W, Sung PS, Park SH, Yoon S, Chang DY, Kim S, Han KH, Kim JK, Rehermann B, Chwae YJ, Shin EC.

Gastroenterology. 2014 May;146(5):1351-60.e1-4. doi: 10.1053/j.gastro.2014.01.054. Epub 2014 Jan 31.

6.

Interferon alpha (IFNα)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5A.

Yang C, Zhao X, Sun D, Yang L, Chong C, Pan Y, Chi X, Gao Y, Wang M, Shi X, Sun H, Lv J, Gao Y, Zhong J, Niu J, Sun B.

Cell Mol Immunol. 2016 Jan;13(1):94-102. doi: 10.1038/cmi.2014.131. Epub 2015 Feb 16.

7.

Antigen processing and presentation in human muscle: cathepsin S is critical for MHC class II expression and upregulated in inflammatory myopathies.

Wiendl H, Lautwein A, Mitsdörffer M, Krause S, Erfurth S, Wienhold W, Morgalla M, Weber E, Overkleeft HS, Lochmüller H, Melms A, Tolosa E, Driessen C.

J Neuroimmunol. 2003 May;138(1-2):132-43.

PMID:
12742663
8.

HCV core and NS3 proteins manipulate human blood-derived dendritic cell development and promote Th 17 differentiation.

Tu Z, Hamalainen-Laanaya HK, Nishitani C, Kuroki Y, Crispe IN, Orloff MS.

Int Immunol. 2012 Feb;24(2):97-106. doi: 10.1093/intimm/dxr104. Epub 2011 Dec 20.

PMID:
22190574
9.

IPS-1 is essential for type III IFN production by hepatocytes and dendritic cells in response to hepatitis C virus infection.

Okamoto M, Oshiumi H, Azuma M, Kato N, Matsumoto M, Seya T.

J Immunol. 2014 Mar 15;192(6):2770-7. doi: 10.4049/jimmunol.1301459. Epub 2014 Feb 14.

10.

Dominating expression of negative regulatory factors downmodulates major histocompatibility complex Class-II expression on dendritic cells in chronic hepatitis C infection.

Tomer S, Chawla YK, Duseja A, Arora SK.

World J Gastroenterol. 2016 Jun 14;22(22):5173-82. doi: 10.3748/wjg.v22.i22.5173.

11.

Contradictory intrahepatic immune responses activated in high-load hepatitis C virus livers compared with low-load livers.

Ishibashi M, Yamaguchi H, Hirotani Y, Sakurada A, Endo T, Sugitani M, Takayama T, Makishima M, Esumi M.

Arch Virol. 2018 Apr;163(4):855-865. doi: 10.1007/s00705-017-3675-8. Epub 2017 Dec 16.

PMID:
29248968
12.

Cathepsin S regulates class II MHC processing in human CD4+ HLA-DR+ T cells.

Costantino CM, Ploegh HL, Hafler DA.

J Immunol. 2009 Jul 15;183(2):945-52. doi: 10.4049/jimmunol.0900921. Epub 2009 Jun 24.

13.

Hepatitis C virus present in the sera of infected patients interferes with the autophagic process of monocytes impairing their in-vitro differentiation into dendritic cells.

Granato M, Lacconi V, Peddis M, Di Renzo L, Valia S, Rivanera D, Antonelli G, Frati L, Faggioni A, Cirone M.

Biochim Biophys Acta. 2014 Jul;1843(7):1348-55. doi: 10.1016/j.bbamcr.2014.04.003. Epub 2014 Apr 12.

14.

Understanding the biological context of NS5A-host interactions in HCV infection: a network-based approach.

Tripathi LP, Kambara H, Chen YA, Nishimura Y, Moriishi K, Okamoto T, Morita E, Abe T, Mori Y, Matsuura Y, Mizuguchi K.

J Proteome Res. 2013 Jun 7;12(6):2537-51. doi: 10.1021/pr3011217. Epub 2013 May 17.

PMID:
23682656
15.

Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.

Mikkelsen M, Holst PJ, Bukh J, Thomsen AR, Christensen JP.

J Immunol. 2011 Feb 15;186(4):2355-64. doi: 10.4049/jimmunol.1001877. Epub 2011 Jan 21.

16.

Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages.

Shi GP, Bryant RA, Riese R, Verhelst S, Driessen C, Li Z, Bromme D, Ploegh HL, Chapman HA.

J Exp Med. 2000 Apr 3;191(7):1177-86.

17.
18.

Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity.

Ding Q, Cao X, Lu J, Huang B, Liu YJ, Kato N, Shu HB, Zhong J.

J Hepatol. 2013 Jul;59(1):52-8. doi: 10.1016/j.jhep.2013.03.019. Epub 2013 Mar 28.

PMID:
23542348
19.

Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice.

Nakagawa TY, Brissette WH, Lira PD, Griffiths RJ, Petrushova N, Stock J, McNeish JD, Eastman SE, Howard ED, Clarke SR, Rosloniec EF, Elliott EA, Rudensky AY.

Immunity. 1999 Feb;10(2):207-17.

Supplemental Content

Support Center